Antispasticity medications: uses and limitations of enteral therapy.
Zafonte
Ross
R
Department of Physical Medicine and Rehabilitation, University of Pittsburgh, and the UPMC Health System, Pittsburgh, Pennsylvania, USA.
Lombard
Lisa
L
Elovic
Elie
E
D015761:4-Aminopyridine / Q000627:therapeutic use; D000085:Acetates / Q000627:therapeutic use; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000588:Amines; D001418:Baclofen / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D003533:Cyproheptadine / Q000627:therapeutic use; D003620:Dantrolene / Q000627:therapeutic use; D013759:Dronabinol / Q000627:therapeutic use; D000077206:Gabapentin; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000316:Adrenergic alpha-Agonists; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D009125:Muscle Relaxants, Central; D018696:Neuroprotective Agents; D012702:Serotonin Antagonists; D001569:Benzodiazepines; D003533:Cyproheptadine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D013759:Dronabinol; D015761:4-Aminopyridine; D003620:Dantrolene; D001418:Baclofen; D005998:Glycine; D010889:Piracetam